Filippo Carannante | Medicine and Dentistry | Best Research Award

Published on 02/08/202402/08/2024 by Book of Award

Dr. Filippo Carannante | Medicine and Dentistry | Best Research Award

UOC Chirurgia Colorettale, Fondazione Policlinico Campus Bio-Medico di Roma | Italy

Author Profile

🎓 Early Academic Pursuits

Dr. Filippo Carannante's academic journey began at the Bio-Medico Campus University of Rome, where he graduated with a degree in Medicine and Surgery, achieving a perfect score of 110/110 cum laude. He completed a specialized training program in General Surgery Residency at the same institution, culminating in a thesis on the oncological outcomes of rectal cancer patients. He further enhanced his expertise with various fellowships and specialized courses, including a PhD program in Biomedical Sciences and Bioethics focused on osteo-oncological diseases.

💼 Professional Endeavors

Dr. Carannante has held several prestigious positions in the field of colorectal and oncological surgery. Since November 2021, he has been a consultant colorectal surgeon at the Campus Bio-Medico Polyclinic Foundation of Rome. In September 2023, he was appointed a professor of Oncological and Digestive Surgery at the Campus Bio-Medico University of Rome. He is also an active member of the Italian Society of Colorectal Surgery (SICCR) and the Italian Society of Surgical Oncology (SICO), where he serves on the young boards, and is part of the Lower GI Group at the American College of Surgeons (ACS).

🔬 Contributions and Research Focus

Dr. Carannante's research contributions are significant, particularly in the areas of colorectal surgery and minimally invasive surgical techniques. His work includes innovative studies on the outcomes of rectal cancer treatments and the feasibility of minimally invasive colectomy in fragile patients. He has also contributed to advancements in laparoscopic and abdominal wall surgery, and has been involved in multiple research projects at renowned institutions across Europe.

🏆 Accolades and Recognition

Dr. Carannante has received numerous awards for his contributions to surgery and research. Notably, he was awarded the "Ettore Ruggieri" Scholarship by the Italian Society of Surgery (SIC) in 2023 and the "Francesco Mazzeo" Award by the Italian Society of Pathology of the Digestive System (SIPAD) in 2024. Additionally, he received the "Best Oral Presentation" award at a national congress for his study on minimally invasive colectomy.

🌍 Impact and Influence

Dr. Carannante's influence extends beyond his immediate professional environment. He serves on the editorial boards of several prestigious journals, including the International Journal of Colorectal Disease and the World Journal of Surgical Oncology. His h-index of 15 and over 828 citations highlight the impact of his research on the global medical community. He is also a reviewer for numerous scientific publications, ensuring the quality and advancement of research in his field.

🏅 Legacy and Future Contributions

Dr. Carannante's legacy is marked by his dedication to advancing the field of colorectal and oncological surgery through both clinical practice and research. His ongoing roles in various surgical societies and academic institutions position him to continue making significant contributions to the medical field. His commitment to education, research, and clinical excellence ensures that his influence will be felt for years to come, inspiring future generations of surgeons and researchers.

Publications 📄

📄Evaluation of Short-Term Effects on Colorectal Surgery Elective Patients after Implementing a Patient Blood Management Program: A Multicenter Retrospective Analysis
Authors: Filippo Carannante, Gabriella Teresa Capolupo, Manuel Barberio, Amedeo Altamura, Valentina Miacci, Martina Zenobia Scopigno, Erika Circhetta, Gianluca Costa, Marco Caricato, Massimo Giuseppe Viola
Journal: [Special Issue: Challenges in Minimally Invasive Colorectal and Abdominal Wall Surgery], Year : 2024

📄Laparoscopic right hemicolectomy: a SICE (Società Italiana di Chirurgia Endoscopica e Nuove Tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?—CoDIG 2 (ColonDx Italian Group)
Authors: Anania, G., Chiozza, M., Campagnaro, A., Zago, M., Zerbinati, A.
Journal: Surgical Endoscopy, Year : 2024

📄Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study
Authors: Rottoli, M., Spinelli, A., Pellino, G., Rausa, E., Celentano, V.
Journal: British Journal of Surgery, Year : 2024

📄Long-term patient-reported outcomes after anti-reflux surgery for gastroesophageal reflux disease and hiatal hernia repair: a single-center experience
Authors: Peltrini, R., Carannante, F., Giovine, G., Capolupo, G.T., Borzomati, D.
Journal: Minerva Surgery, Year : 2023

📄Surgeons’ practice and preferences for the anal fissure treatment: results from an international survey
Authors: Balla, A., Saraceno, F., Shalaby, M., Ziprin, P., Zizzo, M.
Journal: Updates in Surgery, Year : 2023

Gabriella Teresa Capolupo | Medicine and Dentistry | Best Research Award

Published on 02/08/202402/08/2024 by Book of Award

Prof. Gabriella Teresa Capolupo | Medicine and Dentistry | Best Research Award

Fondazione Università Campus Bio Medico di Roma | Italy

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Gabriella Teresa Capolupo's academic journey began with a Degree in Medicine and Surgery from the Faculty of Medicine of the Catholic University of the Sacred Heart of Milan - Rome branch in 2005, achieving a score of 110/110 cum laude. She registered in the Register of Surgeons of Rome in 2006, followed by obtaining a Specialist in General Surgery with honors in 2011. She pursued further specialization, earning a Doctorate in Endocrinology and Metabolic Diseases in 2016 and a Master's degree in Endocrinosurgery and Senology in 2023.

Professional Endeavors 🏥

Since 2012, Prof. Capolupo has held various positions at the University Polyclinic Campus Bio-Medico of Rome. Her roles have included managing professional functions in the Geriatric and Colorectal Surgery Units and conducting surgical interventions, primarily abdominal oncological surgeries, as the first operator, assistant, and assistant-guardian. She has also been actively involved in welfare activities and surgical on-call duties. In recent years, she has served as a Type A researcher with care duties at the Colorectal Surgery Unit and has been a teacher at the School of Specialization in General Surgery and Urology Specialization School.

Contributions and Research Focus 🔬

Prof. Capolupo's research primarily focuses on general and colorectal surgery, with a particular interest in abdominal oncological surgery. Her dedication to research is evident through her involvement in the General Surgery Research Unit and her participation in welfare activities. She has also been a co-supervisor for numerous Master's theses, contributing to several significant publications in the field.

Accolades and Recognition 🏆

Prof. Capolupo has received multiple recognitions throughout her career. In 2021, she won a competition for a researcher in general surgery type A. She achieved national scientific qualification for Professor II band in 2022 and has been a Fellow of the American College of Surgery since 2019. Additionally, she became a Fellow of the International College of Surgery in 2023 and has been an active member of several prestigious scientific societies.

Impact and Influence 🌍

Prof. Capolupo's impact extends beyond her clinical and research work. She has been a significant contributor to the academic community as an editorial board member and reviewer for various scientific journals. Her influence is reflected in her bibliometric indices, with over 80 scientific publications, a h-index of 19, and 2315 citations as of July 2024. Her dedication to teaching and mentorship has shaped the careers of many students and professionals in the medical field.

Legacy and Future Contributions 🔮

Prof. Capolupo's legacy is marked by her extensive contributions to surgical research and education. Her ongoing involvement in academic and clinical settings, coupled with her active participation in scientific societies, ensures her continued influence in the field. Her future contributions are expected to further advance the understanding and practice of general and colorectal surgery, benefiting both patients and the medical community at large.

Publications

📜 Evaluation of Short-Term Effects on Colorectal Surgery Elective Patients after Implementing a Patient Blood Management Program: A Multicenter Retrospective Analysis

👨‍🔬 Authors: Filippo Carannante, Gabriella Teresa Capolupo, Manuel Barberio, Amedeo Altamura, Valentina Miacci, Martina Zenobia Scopigno, Erika Circhetta, Gianluca Costa, Marco Caricato, Massimo Giuseppe Viola
📘 Journal: Special Issue Challenges in Minimally Invasive Colorectal and Abdominal Wall Surgery.
📅 Year: 2024

📜 Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

👨‍🔬 Authors: Bengueddach, A., Tidjane, A., Tabeti, B., Al-Hutheifi, R., Shream, S.
📘 Journal: British Journal of Surgery
📅 Year: 2024

📜 Laparoscopic right hemicolectomy: a SICE (Società Italiana di Chirurgia Endoscopica e Nuove tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?—CoDIG 2 (ColonDx Italian Group)

👨‍🔬 Authors: Anania, G., Chiozza, M., Campagnaro, A., Zago, M., Zerbinati, A.
📘 Journal: Surgical Endoscopy
📅 Year: 2024

📜 Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study

👨‍🔬 Authors: Rottoli, M., Spinelli, A., Pellino, G., Rausa, E., Celentano, V.
📘 Journal: British Journal of Surgery
📅 Year: 2024

📜 Mechanical bowel preparation in elective colorectal surgery: a propensity score-matched analysis of the Italian colorectal anastomotic leakage (iCral) study group prospective cohorts

👨‍🔬 Authors: Catarci, M., Guadagni, S., Masedu, F., Dalmonte, G., La Gioia, G.
📘 Journal: Updates in Surgery
📅 Year: 2024

Nalinda Dissanayaka | Health Professions | Best Researcher Award

Published on 29/07/202429/07/2024 by Book of Award

Mr. Nalinda Dissanayaka | Health Professions | Best Researcher Award

University of Queensland | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Mr. Nalinda Dissanayaka began his academic journey with a Bachelor of Science in Materials Engineering from the University of Moratuwa, Sri Lanka, completed in January 2013. He furthered his education with a Master of Business Administration from the Australian Institute of Business in January 2018 and a Master of Engineering in Engineering Management and Additive Manufacturing from Deakin University in January 2020. He is currently pursuing a Doctor of Philosophy at the University of Queensland, focusing on developing realistic 3D printed neurosurgical training models, with an expected completion in July 2024.

Professional Endeavors 💼

Nalinda's professional career is marked by diverse roles and responsibilities across various industries. He started as a Project Engineer at MAS Holding (Pvt) Ltd in Sri Lanka, moving on to roles at Ansell Lanka (PVT) Ltd as a Process Engineer in Research and Development, and later as a Senior Process Engineer in Manufacturing and R&D. From 2018 to 2021, he served as a Project Manager at Jantec Telecommunication PTY Ltd in Melbourne, VIC. Currently, he is a Doctoral Researcher at the Herstan Biofabrication Institute and the University of Queensland, and a Teaching Assistant at the University of Queensland.

Contributions and Research Focus 🔬

Nalinda's research primarily focuses on the intersection of engineering and medical science, with significant contributions in the development and validation of 3D printed neurosurgical training models. His published works include articles on the evaluation of 3D printed burr hole simulation models and the safety of these models for neurosurgical simulation. His research also explores the mechanical properties of different infill materials produced by various 3D printing technologies, and he has several articles under review in prestigious journals.

Accolades and Recognition 🏆

Throughout his career, Nalinda has received recognition for his contributions to the field of medical engineering. His academic and professional pursuits have earned him memberships in esteemed organizations such as The Institute of Engineers Australia and The Institute of Engineers Sri Lanka. He is also Green Belt Certified in Lean Six Sigma and holds several other professional certifications.

Impact and Influence 🌍

Nalinda's work has had a profound impact on the medical and engineering communities. His innovative research on 3D printed neurosurgical models has advanced the field of medical training, providing safer and more effective simulation tools for neurosurgeons. His presentations at international conferences, such as Formnext 2023 and the Herston Health Precinct Symposium, have further disseminated his findings and influenced practices in medical training and simulation.

Legacy and Future Contributions 🌟

As Nalinda continues his doctoral research, his future contributions promise to further bridge the gap between engineering and medical sciences. His work on 3D printed models is expected to set new standards in neurosurgical training, enhancing the realism and safety of surgical simulations. Nalinda's commitment to continuous improvement and innovation positions him as a leading figure in his field, with a lasting legacy in both engineering and medical research.

Publications 📔

📄 How safe are 3D-printed skull models for neurosurgical simulation? Measurement of airborne particles and VOCs while burr hole drilling
Authors: Dissanayaka, N., Alexander, H., Carluccio, D., Vandi, L.-J., Novak, J.I.
Journal: Rapid Prototyping Journal
Year: 2024

📄 Evaluation of 3D Printed Burr Hole Simulation Models Using 8 Different Materials
Authors: Dissanayaka, N., Maclachlan, L.R., Alexander, H., Jules-Vandi, L., Novak, J.I.
Journal: World Neurosurgery
Year: 2023

Jiang hua Yang | Medicine and Dentistry | Best Researcher Award

Published on 19/07/202420/07/2024 by Book of Award

Dr. Jianghua Yang | Medicine and Dentistry | Best Researcher Award

Yijishan Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianghua Yang began his academic journey in the medical field with a focus on infectious diseases. His foundational studies laid the groundwork for a career dedicated to understanding and combating a variety of infectious diseases. Over the years, Dr. Yang has honed his expertise and developed a deep research interest in several key areas, including tuberculosis, severe fever with thrombocytopenia syndrome, schistosomiasis, and hepatitis.

Professional Endeavors

Dr. Jianghua Yang is currently associated with the Department of Infectious Diseases at Yijishan Hospital of Wannan Medical College in Wuhu, Anhui, China. In his professional role, he has undertaken significant research projects and contributed extensively to the field of infectious diseases. His work is characterized by a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry and collaboration with other researchers.

Contributions and Research Focus

Dr. Yang's research spans several critical areas in infectious diseases. His studies on tuberculosis have been published in reputable journals such as "Tuberculosis (Edinb)" and the "International Journal of Infectious Diseases". His work on severe fever with thrombocytopenia syndrome has appeared in the "Journal of Medical Virology" and the "Japanese Journal of Infectious Diseases". Additionally, Dr. Yang has investigated schistosomiasis, with his findings published in "Scientific Reports" and "Journal of Cancer". His research on hepatitis has been featured in the "European Journal of Gastroenterology & Hepatology" and "BMC Gastroenterology". These contributions have not only enhanced the understanding of these diseases but have also provided valuable insights into their diagnosis, treatment, and management.

Accolades and Recognition

Throughout his career, Dr. Yang has received recognition for his impactful research and contributions to the field of infectious diseases. His publications have been cited by peers, reflecting the significance and influence of his work. Dr. Yang's dedication to advancing medical science has earned him respect and acknowledgment within the academic and medical communities.

Impact and Influence

Dr. Yang's research has had a substantial impact on the understanding and treatment of infectious diseases. His work on tuberculosis and severe fever with thrombocytopenia syndrome has informed clinical practices and guided further research in these areas. By elucidating the complexities of diseases such as schistosomiasis and hepatitis, Dr. Yang has contributed to the development of more effective diagnostic and therapeutic strategies, thereby improving patient care and outcomes.

Legacy and Future Contributions

Dr. Jianghua Yang's legacy in the field of infectious diseases is marked by his significant research contributions and his commitment to advancing medical knowledge. As he continues his work, Dr. Yang is poised to make further groundbreaking discoveries that will enhance the understanding of infectious diseases and lead to better health outcomes worldwide. His ongoing research and dedication to scientific excellence will undoubtedly inspire future generations of researchers and healthcare professionals.

Notable Publications

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome 2024

Prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome 2024

Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica 2023 (1)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment 2022 (4)

Feifei Feng | Health Professions | Best Researcher Award

Published on 10/07/202411/07/2024 by Book of Award

Dr. Feifei Feng | Health Professions | Best Researcher Award

The Second Hospital of Shandong University | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Feifei Feng embarked on her academic journey in clinical medicine, obtaining a Master's degree through a seven-year program at Zhejiang University (2005-2012). She continued her education with a Doctor of Medicine (MD) degree in Internal Medicine from Qilu Medical College, Shandong University (2017-2020). Her academic training laid a robust foundation in both clinical and research aspects of internal medicine, particularly focusing on respiratory and critical care.

Professional Endeavors

Dr. Feng's professional career has been marked by her role as an Associate Chief Physician in the Department of Respiratory and Critical Care Medicine at the Second Hospital of Shandong University (09/2022 - Present). In this capacity, she is responsible for the daily consultation and treatment of patients with respiratory and critical care needs. Her work emphasizes the diagnosis and management of respiratory diseases, with a particular focus on lung cancer and pulmonary fibrosis.

Contributions and Research Focus

Dr. Feng's research has significantly contributed to understanding and treating respiratory diseases. Her research focus includes:

*Silicosis and Pulmonary Fibrosis: Dr. Feng has extensively studied the pathogenesis of silicosis and the therapeutic effects of compounds like Tanshinone IIA in attenuating silica-induced pulmonary fibrosis.

*Cancer Therapy: Her work on the inhibitory effects of polyphyllins and their role in enhancing chemosensitivity of cancer cells to treatments like cisplatin has been groundbreaking.

*Signaling Pathways: She has delved into the molecular mechanisms underlying disease processes, such as the TGF-β1/Smad signaling pathway, EMT, NOX4 inhibition, and Nrf2/ARE signaling activation.

Accolades and Recognition

Dr. Feng's contributions to the field have been widely recognized through numerous publications in high-impact journals. Some of her notable works include:

"Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA" (Biomed Pharmacother, 2024).

"Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling" (Chem Biol Interact, 2020).

Impact and Influence

Dr. Feng's research has had a profound impact on the medical community's understanding of respiratory diseases and their treatment. Her studies on the molecular pathways involved in pulmonary fibrosis and cancer therapy have opened new avenues for developing targeted treatments. By elucidating the mechanisms of disease and identifying potential therapeutic agents, her work has contributed to improved patient outcomes and advanced the field of respiratory medicine.

Legacy and Future Contributions

Dr. Feng continues to make strides in her field through her ongoing clinical practice and research. Her dedication to understanding complex respiratory diseases and finding innovative treatments ensures that her contributions will have a lasting impact. Future research endeavors are likely to build on her current work, exploring new therapeutic targets and improving the quality of care for patients with respiratory diseases. Her legacy will be marked by her commitment to advancing medical science and improving patient health outcomes.

Notable Publications

Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA 2024

Polyphyllin I induces apoptosis and autophagy in temozolomide-resistant glioma via modulation of NRF2 and MAPK-signaling activation 2023 (2)

Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway 2022 (8)

Detection and significance of exosomal mRNA expression profiles in the cerebrospinal fluid of patients with meningeal carcinomatosis 2021 (6)

Astragaloside IV alleviates silica‑induced pulmonary fibrosis via inactivation of the TGF‑β1/Smad2/3 signaling pathway 2021 (23)

Hong Seok Kim | Medicine and Dentistry | Best Researcher Award

Published on 01/07/202406/07/2024 by Book of Award

Dr. Hong Seok Kim | Medicine and Dentistry | Best Researcher Award

Seoul National University | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits

Dr. Hong Seok Kim began his academic journey with a Bachelor of Science in Engineering from Johns Hopkins University (2007-2010). He then pursued a Doctor of Medicine (M.D.) at the College of Medicine, Seoul National University (2011-2015), followed by a Ph.D. from the Graduate School, Seoul National University (2020-2022).

Professional Endeavors

Dr. Kim's professional career is marked by a series of significant positions within the Department of Orthopaedic Surgery at Seoul National University Hospital. Starting as an intern in 2015, he progressed to a resident, fellow, clinical professor, and finally, assistant professor. His roles reflect a steady advancement in his expertise and responsibilities in orthopaedic surgery.

Contributions and Research Focus

Dr. Kim has made substantial contributions to orthopaedic surgery, particularly focusing on hip arthroplasty, osteonecrosis, sarcopenia, and periprosthetic joint infections. His research is well-documented through numerous publications in high-impact journals. He has explored various aspects of orthopaedic surgery, from the biomechanics of hip replacements to the management of complex fractures and the implications of sarcopenia in elderly patients.

Accolades and Recognition

Dr. Kim's work has been recognized with several prestigious awards, including:

Best Presentation Award from the Korean Sarcopenia Association (2021)
Manrye Award from the Korean Orthopedic Association (2021)
International Scholar Award from the Korean Hip Society (2022)
Multiple CiOS reviewer Awards from the Korean Orthopedic Association (2022, 2023)
Best Podium Award from the Korean Hip Society (2024)

Impact and Influence

Dr. Kim's influence extends beyond his clinical and research contributions. His involvement in various professional societies, such as the Korean Orthopedic Association, Korean Hip Society, and Korean Society for Bone and Mineral Research, underscores his commitment to advancing the field. His work has influenced clinical practices, particularly in the management of hip fractures and the use of novel implant designs in total hip arthroplasty.

Legacy and Future Contributions

Dr. Kim's legacy is built on his dedication to improving patient outcomes through innovative surgical techniques and rigorous research. As he continues to publish influential papers and participate in international collaborations, his future contributions are likely to shape the evolution of orthopaedic surgery, particularly in the areas of hip arthroplasty and the management of musculoskeletal conditions in the elderly.

Notable publications

Computed Tomography (CT) Evaluation of Alumina Ceramic-on-Ceramic Total Hip Arthroplasty with More than 20 years of Follow-Up: Is a Follow-Up CT Scan Necessary? 2024

Novel radiologic indices for stem type decision in total hip arthroplasty in patients with metaphyseo-diaphyseal mismatched Dorr A proximal femur 2024

Outcome and complication rate of total hip arthroplasty in patients younger than twenty years: which bearing surface should be used? 2024 (2)

Optimization of Acetabular Cup Abduction by Adjusting Pelvic Pitch 2024

A 10- to 12-year follow-up study of delta ceramic-on-ceramic total hip arthroplasty 2023 (5)

Hikari Okada | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on 27/06/202427/06/2024 by Book of Award

Assoc Prof Dr. Hikari Okada | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Kanazawa University, Graduate School of Medical Sciences | Japan

Author Profile

Scopus

Early Academic Pursuits

Prof. Dr. Hikari Okada's academic journey began with a Pharm.D. from the Faculty of Pharmaceutical Sciences at Hokuriku University, Japan, in 2007. His early interest in pharmaceutical sciences led him to pursue a Master's degree in Molecular Biology at the Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan, which he completed in 2009. He further honed his expertise by obtaining a Ph.D. in Molecular Biology from the same institution in 2013.

Professional Endeavors

Dr. Okada's professional career started as a Research Associate in the Department of Gastroenterology at the Graduate School of Medical Sciences, Kanazawa University. From 2013 to 2015, he worked as a VHFJ fellow and continued his research in the same department as an AMED fellow from 2016 to 2018. He was appointed as an Assistant Professor in the Department of Integrative Medicine for Longevity at the Graduate School of Medical Sciences in 2019. Since 2022, Dr. Okada has been serving as an Associate Professor in Information-Based Medicine Development at the same institution.

Contributions and Research Focus

Dr. Okada's research primarily focuses on molecular biology, gastroenterology, and integrative medicine. His significant contributions include the study of molecular mechanisms in hepatocellular carcinoma, liver cancer stem cells, and hepatitis B and C viruses. His work on the role of Mint3 in triple-negative breast cancer and the involvement of endothelial lipase in hepatitis B virus infection has been widely recognized. Dr. Okada has published extensively, with numerous papers in high-impact journals, highlighting his commitment to advancing medical science.

Accolades and Recognition

Throughout his career, Dr. Okada has received several prestigious awards. In 2013, he was honored with the 11th Takayasu Award for Best Article and the 26th Taisyo Toyama Award, recognizing his outstanding contributions to medical research.

Impact and Influence

Dr. Okada's research has had a significant impact on the fields of molecular biology and gastroenterology. His work on cancer stem cells and viral infections has paved the way for new therapeutic approaches and improved understanding of disease mechanisms. His contributions have influenced both clinical practices and ongoing research in these areas.

Legacy and Future Contributions

Dr. Okada's legacy is marked by his dedication to research and education. His pioneering work in molecular biology and gastroenterology continues to inspire new generations of scientists and researchers. As an Associate Professor, he is actively involved in mentoring young researchers, fostering a collaborative and innovative research environment. Dr. Okada's future contributions are expected to further advance our understanding of complex diseases and lead to the development of novel therapeutic strategies.

Notable Publications

Mint3-depletion-induced energy stress sensitizes triple-negative breast cancer to chemotherapy via HSF1 inactivation 2023

Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression 2023

Functional involvement of endothelial lipase in hepatitis B virus infection 2023 (2)

Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on 20/04/202420/04/2024 by Book of Award

Mr. Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Hebrew University of Jerusalem | Israel

Author Profile

Scopus

Orcid

Early Academic Pursuits

Mr. Jairus Nandwa embarked on his academic journey with a Bachelor of Technology in Industrial Microbiology and Biotechnology from The Technical University of Mombasa, Kenya. He further pursued a Master of Science in Biosciences at COMSATS University Islamabad, Pakistan, and is currently pursuing a PhD in Genetics at The Hebrew University of Jerusalem, focusing on circular RNAs, SNORDS, and miRNAs in cancer under the guidance of Professor Ruth Sperling.

Professional Endeavors

With a robust academic background, Mr. Nandwa engaged in various research experiences, including his role as a Graduate Student/Research Student at the Cancer Genetics and Epigenetics Lab, COMSATS University, Pakistan. He also served as a Laboratory Analyst during his BTech internship at the Regional Veterinary Investigation Laboratory, Kenya.

Contributions and Research Focus

Mr. Nandwa's research interests span non-coding RNAs in gene expression regulation, tumor microenvironment, biomarker/therapeutic discovery, DNA repair mechanisms, and biological data analysis. He has authored several publications and presented his research at esteemed conferences globally.

Accolades and Recognition

His notable publications include research on miRNA-4716–3p and its association with blood cancer pathogenesis, earning recognition in Non-Coding RNA Research. He has also received awards such as the Queen Elizabeth Commonwealth Scholarship and First Class Honors in BTech Industrial Microbiology and Biotechnology.

Impact and Influence

Mr. Nandwa's contributions extend beyond academia, with leadership roles in cancer education initiatives and community service engagements. His research and volunteer efforts demonstrate a commitment to advancing scientific knowledge and addressing societal challenges.

Legacy and Future Contributions

As Mr. Nandwa continues his doctoral studies and research pursuits, his dedication to understanding the intricacies of cancer biology and contributing to innovative solutions positions him as a promising researcher in the field of genetics. His leadership, academic achievements, and community impact foreshadow a legacy of scientific excellence and social responsibility.

Notable Publications

In silico analysis of RPS4X (X-linked ribosomal protein) with active components from black seed (Nigella sativa) for potential treatment of multiple sclerosis 2024

Targeting allosteric sites on PDK-1 and PLK-1 with bioactive compounds from Daucus carota as a potential therapy for triple-negative breast cancer 2023

Chansokhon Ngan | Medicine and Dentistry | Best Researcher Award

Published on 10/04/202410/04/2024 by Book of Award

Mr. Chansokhon Ngan | Medicine and Dentistry | Best Researcher Award

West China Hospital of Sichuan University | China

Author Profile

Orcid

Early Academic Pursuits

Mr. Chansokhon Ngan embarked on his academic journey with a fervent dedication to advancing knowledge in critical care medicine. As a PhD student specializing in Critical Care Medicine at West China Hospital of Sichuan University, he cultivated a strong foundation in research methodologies, data analysis, and clinical practice. His academic pursuits equipped him with the necessary skills to address complex clinical challenges and contribute meaningfully to patient care and medical research.

Professional Endeavors

Throughout his career, Mr. Ngan has been committed to advancing knowledge in critical care medicine through his research endeavors. One of his notable studies, titled "Cardiac index and heart rate as prognostic indicators for mortality in septic shock: A retrospective cohort study from the MIMIC-IV," exemplifies his dedication to excellence in research. Published in Heliyon Journal, this study investigated the relationship between cardiac index (CI), heart rate (HR), and mortality in septic shock patients, utilizing sophisticated data analysis techniques.

Contributions and Research Focus

Mr. Ngan's research focus revolves around critical illnesses, such as septic shock and acute respiratory distress syndrome (ARDS). His contributions to the field include studies on prognostic indicators for mortality in septic shock and predicting the early incidence and stratification of ARDS. Additionally, he is engaged in investigating the application of critical care ultrasound in managing acute respiratory and circulatory dysfunction, aiming to enhance clinical practices and improve patient outcomes.

Accolades and Recognition

Mr. Ngan's dedication to excellence in research has earned him recognition in the medical community. His study on prognostic indicators for mortality in septic shock, published in Heliyon Journal, showcases his commitment to advancing knowledge in critical care medicine. His contributions have been acknowledged for their implications for clinical practice and patient care.

Impact and Influence

Mr. Ngan's research endeavors have made a significant impact on the field of critical care medicine. By investigating prognostic indicators for mortality in septic shock and exploring the application of critical care ultrasound, he has contributed valuable insights that have the potential to improve patient outcomes and enhance clinical practices. His work has influenced the way healthcare providers monitor and manage critical illnesses, leading to more informed decision-making and improved patient care.

Legacy and Future Contributions

As Mr. Ngan continues his academic journey, he remains dedicated to making meaningful contributions to the field of critical care medicine. His research legacy encompasses a commitment to excellence, innovation, and improving patient outcomes. Through his ongoing endeavors, he aims to advance knowledge in critical care medicine, ultimately leaving a lasting impact on the field and paving the way for enhanced clinical practices and patient care.

Notable Publications

Xin Feng | Health Professions | Best Researcher Award

Published on 02/03/202402/03/2024 by Book of Award

Prof Dr. Xin Feng | Health Professions | Best Researcher Award

Qilu hospital of Shandong University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits

Prof. Dr. Xin Feng began his academic journey at Shandong University, where he pursued medical and doctoral degrees. His passion for otolaryngology led him to undertake post-doctoral training at the Asthma and Allergic Diseases Center, University of Virginia, where he honed his expertise in rhinologic diseases and allergies.

Professional Endeavors

As Deputy Director of the Department of Otorhinolaryngology at Qilu Hospital of Shandong University and Deputy Director of the National Health Commission (NHC) Key Laboratory of Otorhinolaryngology, Prof. Dr. Xin Feng has played pivotal roles in advancing research and clinical practice in his field. He has also served in leadership positions in various medical associations, including the Otolaryngology Head and Neck Surgery Branch of the Chinese Medical Association.

Contributions and Research Focus

Prof. Dr. Xin Feng's research encompasses a wide range of topics, including nasal polys and asthma, chronic rhinosinusitis, and allergic rhinitis. He has been the principal investigator for several prestigious research programs, focusing on elucidating the pathogenesis of rhinologic diseases and exploring innovative treatment modalities.

Accolades and Recognition

Prof. Dr. Xin Feng's contributions to the field of otolaryngology have been recognized with numerous awards and honors, including the Taishan Scholar Program, Outstanding Young Doctor Prize of Shandong Province, and the New Technology Award of Shandong Medical Association. His outstanding scientific research achievements have earned him accolades from both national and international medical communities.

Impact and Influence

Through his extensive publications in renowned journals such as J Allergy Clin Immunol and Am J Respir Cell Mol Biol, Prof. Dr. Xin Feng has significantly contributed to advancing the understanding of rhinologic diseases and allergic conditions. His research findings have not only enhanced clinical management strategies but also paved the way for the development of novel diagnostic tools and therapeutic interventions.

Legacy and Future Contributions

Prof. Dr. Xin Feng's legacy in otolaryngology and allergy research is characterized by his unwavering commitment to improving patient outcomes and advancing medical knowledge. His future contributions are anticipated to further deepen our understanding of rhinologic diseases and allergic conditions, ultimately leading to better treatment options and improved quality of life for patients worldwide.

Notable Publications

Expression Profiles of Matrix Metalloproteinases and Their Inhibitors in Nasal Polyps 2024

Transcriptomic analysis of asthma and allergic rhinitis reveals CST1 as a biomarker of unified airways 2023 (7)

Identification of key genes and pathways in chronic rhinosinusitis with nasal polyps and asthma comorbidity using bioinformatics approaches 2022 (6)

Improvement of Subjective Olfactory Dysfunction in Chronic Rhinosinusitis With Nasal Polyps After Endoscopic Sinus Surgery 2022 (2)